Noevir Holdings Co Ltd
TSE:4928

Watchlist Manager
Noevir Holdings Co Ltd Logo
Noevir Holdings Co Ltd
TSE:4928
Watchlist
Price: 4 760 JPY -1.55%
Market Cap: 162.6B JPY
Have any thoughts about
Noevir Holdings Co Ltd?
Write Note

Noevir Holdings Co Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Noevir Holdings Co Ltd
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Noevir Holdings Co Ltd
TSE:4928
Total Receivables
ÂĄ10.8B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-1%
Shiseido Co Ltd
TSE:4911
Total Receivables
ÂĄ135.6B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
2%
Rohto Pharmaceutical Co Ltd
TSE:4527
Total Receivables
ÂĄ68.5B
CAGR 3-Years
13%
CAGR 5-Years
10%
CAGR 10-Years
8%
Kao Corp
TSE:4452
Total Receivables
ÂĄ219.6B
CAGR 3-Years
5%
CAGR 5-Years
2%
CAGR 10-Years
4%
Kose Corp
TSE:4922
Total Receivables
ÂĄ42.9B
CAGR 3-Years
8%
CAGR 5-Years
-2%
CAGR 10-Years
5%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Total Receivables
ÂĄ39.6B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
1%
No Stocks Found

Noevir Holdings Co Ltd
Glance View

Market Cap
162.6B JPY
Industry
Consumer products

In the versatile world of beauty and wellness, Noevir Holdings Co Ltd. stands as a testament to astute innovation combined with a well-honed business acumen. Founded in Japan, this company has expertly navigated the delicate balance of tradition and modernity to emerge as a prominent figure in the skincare and cosmetic industries. Noevir's strategy is rooted in the meticulous formulation of its products, drawing inspiration from natural ingredients, which reflects the company’s keen attention to quality and detail. By leveraging advanced research and development techniques, Noevir crafts a diverse range of skincare and personal care products designed to cater to the discerning needs of its clientele. They operate primarily through direct sales channels, allowing them to maintain a personal relationship with their customers, understanding their preferences deeply and ensuring a consistent brand experience. Financially, Noevir Holdings generates revenue by employing a multi-faceted business model, anchoring itself in both domestic and international markets. Besides its leading role in the cosmetics sector, the company diversifies through its involvement in pharmaceuticals and health foods, broadening its portfolio to mitigate market risks. This diversity not only stabilizes the company’s revenue streams but also aligns with the increasing consumer emphasis on holistic health and wellness solutions. Noevir's ability to anticipate and respond to market trends ensures its growth trajectory, having firmly established its brand in the Asian market while progressively expanding its footprint across regions. As a result, the company's strategy encompasses not just product innovation but also a robust marketing and distribution network that reinforces its position as a leader in the beauty and wellness industry.

Intrinsic Value
5 050.03 JPY
Undervaluation 6%
Intrinsic Value
Price

See Also

What is Noevir Holdings Co Ltd's Total Receivables?
Total Receivables
10.8B JPY

Based on the financial report for Sep 30, 2024, Noevir Holdings Co Ltd's Total Receivables amounts to 10.8B JPY.

What is Noevir Holdings Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
-1%

Over the last year, the Total Receivables growth was -20%. The average annual Total Receivables growth rates for Noevir Holdings Co Ltd have been -4% over the past three years , -5% over the past five years , and -1% over the past ten years .

Back to Top